Our experience with enzyme-linked immunospot assay in the laboratory diagnostics of lyme borreliosis 
Results
From the number of 42 patients we detected positive LymeSpot test only in 4 of them (9,5%), a cutoff value in 3 patients (7,1%). From the group of 42 patients were simultaneously performed ELISA and WB in 26 persons.
In this group we found positive LymeSpot in 4 patients and cutoff value in 2 patients. In the group of 4 patients with positive LymeSpot was detected higher level of IgM antibodies in 3 patients and only IgG antibodies in 1 patient. They were patients with clinical manifestations of LB who were treated with antibiotics afterwards. Among 20 patients with negative results of LymeSpot these findings correlated with antibody response in 8 patients (40%). In this group we detected seronegative finding (IgM-IgG-) or finding of passing through LB (IgM-IgG+). In other 12 patients with negative LymeSpot test we detected serological finding of beginning (IgM +IgG-) or running LB (IgM+IgG+). They were mostly patients without clear symptoms of LB, patients with long-term positivity of IgM antibodies without clinical manifestations of LB or patients after antibiotic therapy.
Conclusions
Our first experience shows that results of LymeSpot test better correlate with clinical findings and LB activity as well as can be effective marker of success of antibiotic therapy.
